EUVIMED · CrossrefJournal
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
ISSN 1741-1343 · SAGE Publications
Latest articles
Navigating drug delivery: Nanostructured lipid carriers (NCLs) to enhanced permeability and optimization of BCS class 2 drugs in Peyer’s patch targeting
From cost containment to supply resilience: Japan’s evolving policy architecture for generic medicines
Physicochemical changes in unit-dose packaging of generic olmesartan medoxomil tablets and metformin hydrochloride tablets
Making medicine access governable: Payment and procurement architectures for sustainable pharmaceutical access
Divergent philosophies in pharmaceutical intellectual property: A comparative analysis of regulatory, pricing, and litigation regimes in the United States, European union, and pro-public health jurisdictions
Liposomes in the intersection of innovation: Basic structures and preparation technologies to the recent advancements in therapies and future perspectives
EU legal and regulatory update February 2026
Access to asthma medicines in resource-limited settings: A cross-sectional study in Enugu State, Nigeria
The business of survival: Generic medicines at the intersection of health, policy, and structural resilience in Lebanon
Competition isn’t enough: Medicare still overpays for abiraterone
Strengthening the Indian generics sector: Business opportunities, quality assurance and patient welfare
The journal of generic medicines – Editorial June 2026
EU legal and regulatory update November 2025
The journal of generic medicines – Editorial March 2026
A review and analysis of product recall for pharmaceutical drug product
Effects of new formulation strategy on life cycle management in the US pharmaceutical industry
Opportunities and Challenges to Implementing Quality by Design Approach in Generic Drug Development
Price Comparison between Innovator and Generic Medicines Sold by Community Pharmacies in the State of Penang, Malaysia
Fluvastatin and Atorvastatin: A Comparison of Patent Protection (Part 2)
Fluvastatin and Atorvastatin: A Comparison of Patent Protection (Part 1)
EU Legal and Regulatory Update
Climate of Change Continues in Canada
Evaluating Community Pharmacists' Perceptions and Practices on Generic Medicines: A Pilot Study from Peninsular Malaysia
Abbott v Torpharm : The Contours of Contempt
EU Legal and Regulatory Update
Book Review
Tropical Disease Priority Review Vouchers: Potential Incentives and Opportunities for Generic Manufacturers
Prevailing against Cost-Leader Competitors in the Pharmaceutical Industry
Biogen Insufficiency Explained; Alendronate in Netherlands; Behaviour Relevant to Injunction; Perindopril Evergreening Criticised; ‘Negative Term’ SPCs'; New Dosage Regimes
Veterinary Generics: An Enigma among Niche Markets
EUVIMED